Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: R06AX27

Dasselta(desloratadine)

Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal;Urticaria

Marketing Authorisation Holder: Krka, d.d., Novo mesto

EMA Authorisation: 28/11/2011

INN: desloratadine

Indication

Dasselta is indicated for the relief of symptoms associated with: allergic rhinitis; urticaria.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Dasselta — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.